-
EXPRESSION EVALUATION OF HER-2 AND β1 INTEGRIN IN HER-2+ BREAST CANCER CELLS LINES AFTER TREATMENT WITH TRASTUZUMAB
Vol 3, 2022 -154928 -
THE MOLECULAR SIGNATURE OF EXOSOME-RELATED PROTEINS IS DISRUPTED BY HISTONE DEACETYLASE ACTIVITY INHIBITION IN THE GLIOBLASTOMA SECRETOME: IN SILICO AND IN VIVO CHARACTERIZATIO
Vol 3, 2022 -155250 -
INCREASED MIGRATORY CAPACITY OF HER2+ BREAST CANCER TUMOR CELLS AFTER TREATMENT WITH TRASTUZUMAB
Vol 3, 2022 -155221
Publicações em outros proceedings
-
XVIII SO 2024
INVESTIGATING THE ROLE OF β1 INTEGRIN IN HER-2 POSITIVE BREAST CANCER
-
XV SO 2021
THE MOLECULAR SIGNATURE OF PROTEINS ASSOCIATED WITH EXOSOMES IS DISRUPTED BY HISTONE DEACETYLASE ACTIVITY INHIBITION IN THE GLIOBLASTOMA SECRETOME: IN SILICO CHARACTERIZATION
-
XIV SO 2020
“IDENTIFICATION AND CLASSIFICATION OF EXCLUSIVE PROTEINS FROM HER-2 POSITIVE BREAST CANCER SENSITIVE TO TREATMENT WITH TRASTUZUMAB”
-
XIV SO 2020
PROTEOMIC ANALYSIS OF HER-2 POSITIVE BREAST CANCER RESISTANT TO TRASTUZUMAB TREATMENT
-
XIV SO 2020
Inhibition of the Histone Deacetylase activity impacts on Glioblastoma secretoma and disrupts the molecular signature of the Tumor Extracellular Matrix
Discussões Científicas de Qualidade
Com ~200 mil publicações revisadas por pesquisadores do mundo todo, o Galoá impulsiona cientistas na descoberta de pesquisas de ponta por meio de nossa plataforma indexada.
Confira nossos produtos e como podemos ajudá-lo a dar mais alcance para sua pesquisa:
